Eric J Burks, MD
Clinical Associate Professor, Pathology
Biography
Eric Burks, MD is a Clinical Associate Professor of Pathology at the Chobanian and Avedisian School of Medicine. After graduating medical school, he had two fellowship: one in Surgical Pathology at Harvard Medical School and another in Hematopathology at Johns Hopkins Medical Institution. Only recently, as of April 2018, did he join Boston University. With him he brings extensive experience as a lecturer, mentor, and physician. His research is particularly notable given that he has received both the American Cancer Society Institutional Research Grant Medical Student Award and the American Society of Hematology Medical Student Award.
Other Positions
- Member, BU-BMC Cancer Center, Boston University
Education
- University of New Mexico School of Medicine, MD
- New Mexico State University, BS
Publications
- Published on 11/13/2023
Ma L, Sullivan TB, Rieger-Christ KM, Yambayev I, Zhao Q, Higgins SE, Yilmaz OH, Sultan L, Servais EL, Suzuki K, Burks EJ. Vascular invasion predicts the subgroup of lung adenocarcinomas =2.0 cm at risk of poor outcome treated by wedge resection compared to lobectomy. JTCVS Open. 2023 Dec; 16:938-947. PMID: 38204657.
Read at: PubMed - Published on 7/8/2023
Jamil ML, Perecman A, Sherman A, Sullivan T, Christ K, Hansma A, Burks E, Vanni AJ. Urinary microbiome differences between lichen sclerosus induced and non-lichen sclerosus induced urethral stricture disease. World J Urol. 2023 Sep; 41(9):2495-2501. PMID: 37421420.
Read at: PubMed - Published on 12/25/2022
Suaiti L, Sullivan TB, Rieger-Christ KM, Servais EL, Suzuki K, Burks EJ. Vascular Invasion Predicts Recurrence in Stage IA2-IB Lung Adenocarcinoma but not Squamous Cell Carcinoma. Clin Lung Cancer. 2023 May; 24(3):e126-e133. PMID: 36631388.
Read at: PubMed - Published on 10/27/2022
Zheng Y, Gindra RH, Green EJ, Burks EJ, Betke M, Beane JE, Kolachalama VB. A Graph-Transformer for Whole Slide Image Classification. IEEE Trans Med Imaging. 2022 Nov; 41(11):3003-3015. PMID: 35594209.
Read at: PubMed - Published on 10/26/2022
Prokaeva T, Klimtchuk ES, Feschenko P, Spencer B, Cui H, Burks EJ, Aslebagh R, Muneeruddin K, Shaffer SA, Varghese E, Berk JL, Connors LH. An additive destabilising effect of compound T60I and V122I substitutions in ATTRv amyloidosis. Amyloid. 2023 Jun; 30(2):141-152. PMID: 36286264.
Read at: PubMed - Published on 9/28/2022
Kalantzakos TJ, Sebel LE, Trussler J, Sullivan TB, Burks EJ, Sarita-Reyes CD, Canes D, Moinzadeh A, Rieger-Christ KM. MicroRNA Associated with the Invasive Phenotype in Clear Cell Renal Cell Carcinoma: Let-7c-5p Inhibits Proliferation, Migration, and Invasion by Targeting Insulin-like Growth Factor 1 Receptor. Biomedicines. 2022 Sep 28; 10(10). PMID: 36289686.
Read at: PubMed - Published on 7/25/2022
Yambayev I, Sullivan TB, Rieger-Christ KM, Servais EL, Stock CT, Quadri SM, Sands JM, Suzuki K, Burks EJ. Vascular invasion identifies the most aggressive histologic subset of stage I lung adenocarcinoma: Implications for adjuvant therapy. Lung Cancer. 2022 Sep; 171:82-89. PMID: 35932520.
Read at: PubMed - Published on 5/14/2022
Prokaeva T, Joshi T, Klimtchuk ES, Gibson VM, Spencer B, Siddiqi O, Nedelkov D, Hu Y, Berk JL, Cuddy SAM, Dasari S, Chiu A, Choate LA, McPhail ED, Cui H, Chen H, Burks EJ, Sanchorawala V, Connors LH. A novel substitution of proline (P32L) destabilises ß2-microglobulin inducing hereditary systemic amyloidosis. Amyloid. 2022 Dec; 29(4):255-262. PMID: 35575118.
Read at: PubMed - Published on 12/15/2021
Kohli H, Childs B, Sullivan TB, Shevtsov A, Burks E, Kalantzakos T, Rieger-Christ K, Vanni AJ. Differential expression of miRNAs involved in biological processes responsible for inflammation and immune response in lichen sclerosus urethral stricture disease. PLoS One. 2021; 16(12):e0261505. PMID: 34910765.
Read at: PubMed - Published on 11/10/2021
Burks EJ, Zhang J, Sullivan TB, Shi X, Sands JM, Regis SM, McKee BJ, McKee AB, Zhang S, Liu H, Liu G, Spira A, Beane J, Lenburg ME, Rieger-Christ KM. Pathologic and gene expression comparison of CT- screen detected and routinely detected stage I/0 lung adenocarcinoma in NCCN risk-matched cohorts. Cancer Treat Res Commun. 2021; 29:100486. PMID: 34794107.
Read at: PubMed
View 38 more publications: View full profile at BUMC